Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 3/20 | 0.65 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1956807 | 0.90 | BCL2 (0.77) | BCL2BCL2L1 | |
| SCHEMBL1955172 | 0.89 | BCL2 (0.74) | BCL2 | |
| SCHEMBL19424619 | 0.85 | BCL2 (0.74) | BCL2BCL2L1 | |
| SCHEMBL1957655 | 0.85 | BCL2 (0.69) | BCL2BCL2L1 | |
| SCHEMBL1955765 | 0.85 | BCL2 (0.87) | BCL2 | |
| SCHEMBL1957789 | 0.85 | BCL2 (0.82) | BCL2 | |
| SCHEMBL1742386 | 0.85 | BCL2 (0.63) | BCL2 | |
| SCHEMBL19424614 | 0.84 | BCL2 (0.76) | BCL2BCL2L1 | |
| SCHEMBL1958650 | 0.83 | BCL2 (0.71) | BCL2 | |
| SCHEMBL1955530 | 0.83 | BCL2 (0.74) | BCL2BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2507229-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | Abbott Laboratories (US) | 2012-10-10 | — | — | EP | claimed |
| WO-2011068561-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2011-06-09 | — | — | WO | claimed |
| EP-2507229-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | Abbott Laboratories (US) | 2012-10-10 | — | — | EP | disclosed |
| WO-2011068561-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2011-06-09 | — | — | WO | disclosed |